Lexicon Pharmaceuticals Inc (LXRX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Lexicon Pharmaceuticals Inc   (NASDAQ: LXRX)
 

Lexicon Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Lexicon Pharmaceuticals Inc 's inventory turnover ratio sequentially decreased to 0.75 in the second quarter 2026, unsurprisingly, as the Lexicon Pharmaceuticals Inc markets continue to deteriorate, and LXRX's faces growing challenges to bring down its inventories. Lexicon Pharmaceuticals Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 487 days, from 230 days, in the Mar 31 2026 quarter.

Within Healthcare sector 335 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1699, from total ranking in the first quarter 2026 at 1965.

LXRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lexicon Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LXRX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 611.9 % 37.31 % 21.65 % -75.16 % -71.28 %
Y / Y Cost of Sales Growth 18.18 % 260 % -42.24 % -85.92 % -80.12 %
Inventory Turnover Ratio (TTM) 0.75 1.59 1.36 2.22 1.56
LXRX's Total Ranking # 1699 # 1965 # 1523 # 1758 # 1782
Average inventory processing period 487 229 269 164 234
Seq. Inventory Growth 333.33 % -1.78 % 77.85 % -5.95 % -16.42 %
Seq. Cost of Sales Growth -63.89 % -46.27 % 1910 % -69.7 % 10 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 102
Healthcare Sector # 336
Overall Market # 1699

Inventory Turnover Ratio Statistics
High Average Low
2.22 1.02 0.33
(Sep 30 2025)   (Mar 31 2024)



LXRX Company Profile >> Back to LXRX Efficiency Comparisons >> Compare LXRX Inventory Turnover Ratio to its Competitors

Financial Statements
Lexicon Pharmaceuticals Inc 's Inventories $ 1 Millions Visit LXRX's Balance sheet
Lexicon Pharmaceuticals Inc 's Cost of Revenues TTM $ 0 Millions Visit LXRX's Income Statement
What are LXRX's Sales? Visit LXRX's Sales by Segment

Other Inventory Turnover Ratios
Lexicon Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LXRX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LXRX's Competitors
Inventory Turnover Ratio for LXRX's Suppliers
Inventory Turnover Ratio for LXRX's Customers

You may also want to know
LXRX's Sales Growth Rates LXRX's Pe Price to earnings ratio LXRX's Receivables Turnover Ratio LXRX's Stock Quote
LXRX's Net Income Growth Rates LXRX's Ps Price to Sales ratio LXRX's Sales per Employee LXRX's Asset Turnover Ratio
LXRX's Net Margin LXRX's Pb Price to Book ratio LXRX's Financial Strength Ratios LXRX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Profound Medical Corp   0.81 $ 5.385  Millions$ 7  Millions
Blue Water Vaccines Inc  0.78 $ 0.127  Millions$ 0  Millions
Milestone Scientific Inc   0.77 $ 2.804  Millions$ 4  Millions
Sensus Healthcare Inc   0.76 $ 11.924  Millions$ 16  Millions
Nuvation Bio Inc   0.76 $ 10.000  Millions$ 13  Millions
Lexicon Pharmaceuticals Inc   0.75 $ 0.358  Millions$ 0  Millions
Picard Medical Inc   0.71 $ 4.811  Millions$ 7  Millions
Immunocore Holdings Plc  0.67 $ 4.738  Millions$ 7  Millions
Gyre Therapeutics Inc   0.65 $ 6.807  Millions$ 10  Millions
Liquidia Corporation  0.64 $ 18.181  Millions$ 28  Millions
Bioxcel Therapeutics Inc   0.64 $ 0.348  Millions$ 1  Millions
Envoy Medical Inc   0.64 $ 1.005  Millions$ 2  Millions
X4 Pharmaceuticals Inc  0.63 $ 2.930  Millions$ 5  Millions
Organogenesis Holdings Inc   0.62 $ 19.764  Millions$ 32  Millions
Xeris Biopharma Holdings Inc   0.62 $ 45.029  Millions$ 73  Millions
Lenz Therapeutics Inc   0.62 $ 1.774  Millions$ 3  Millions
Jaguar Health Inc   0.57 $ 4.921  Millions$ 9  Millions
Travere Therapeutics Inc   0.57 $ 8.263  Millions$ 14  Millions
Cvrx inc   0.57 $ 6.981  Millions$ 12  Millions
Biomarin Pharmaceutical Inc  0.57 $ 813.588  Millions$ 1,434  Millions
Verastem Inc   0.54 $ 1.128  Millions$ 2  Millions
Ionis Pharmaceuticals Inc   0.53 $ 9.873  Millions$ 19  Millions
Heron Therapeutics Inc   0.53 $ 45.572  Millions$ 86  Millions
Orchestra Biomed Holdings Inc   0.52 $ 0.157  Millions$ 0  Millions
Sintx Technologies Inc   0.51 $ 0.627  Millions$ 1  Millions
Siga Technologies Inc  0.50 $ 24.494  Millions$ 49  Millions
Ardelyx inc   0.50 $ 25.401  Millions$ 51  Millions
Orthopediatrics Corp  0.49 $ 65.142  Millions$ 134  Millions
Scienture Holdings Inc   0.47 $ 0.101  Millions$ 0  Millions
Co diagnostics Inc   0.44 $ 0.412  Millions$ 1  Millions

Date modified: 2026-09-08T13:54:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.